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Abstract:
Objective: Present study involved identification of  offending out-door aero-allergens and associated genetic pathway in nas-
so-bronchial asthma among Kolkata population. 
Methods: Skin-prick test was done among 950 asthmatic patients against 11 common aero-allergens and total serum IgE con-
centration was measured. PCR-RFLP was done in patients and non-asthmatic control (n=220 in each) to characterize functional 
polymorphism, C(-159)T, of  CD14, a positional candidate gene for allergy. Association of  genetic polymorphisms was made 
with clinico-pathological conditions. 
Results: We identified Cocos nucifera as the most common aero-allergen sensitizer among atopic patients in Kolkata. Patients with 
childhood-onset asthma were significantly more sensitive towards aero-allergens and had significantly higher serum IgE level 
than those of  adult-onset (p< 0.0001). No significant difference was found in distribution of  SNP genotypes of  CD14 among 
case and control (p=0.178). However among patients, frequency of  C allele is significantly higher in childhood-onset group than 
that of  adult-onset and concordantly in former CC genotype was associated with significant higher level of  serum IgE than CT 
and TT. 
Conclusion: In Kolkata, pollen is a common out-door aero-allergen and Cocos nucifera is predominant among pollens. Child-
hood-onset and adult-onset of  asthma showed significant difference in allergen sensitivity as well as genetic background with 
respect to CD14 polymorphism.
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Introduction
Asthma is the most common type of  atopic manifestation 
characterized by respiratory symptoms, narrowing of  air-
ways, and inflammation1. Prevalence of  asthma is gradu-
ally increasing worldwide including developing countries 
and in India alone, roughly 15% of  the people suffer 
from this disease2,3. Development of  asthma in individual 
depends on both environmental stimuli like aero-allergen 
and genetic factors4. Exposure of  aero-allergen serves as 
a trigger for worsening of  asthma and therefore identi-
fication of  disease specific allergen is important for de-
signing avoidance strategy5. Airborne pollens and molds 
produced by flowering plants and fungi are the most im-
portant factors of  asthma and India being a climatically 
diverse country supports huge diversity of  such aero-al-
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lergens in different regions. In asthma, atopic response 
is characterized by allergic inflammation induced by Th2 
(T-helper type-2) derived cytokines and production of  
allergen specific immunoglobulin-E (IgE)6. The gene en-
coding Cluster Differentiation antigen (CD14) is localized 
on chromosomal 5q31.1 region which is associated with 
both asthma and total serum IgE concentration7.  Actual-
ly CD14 is a pattern recognition factor that plays a central 
role in innate immunity through recognition of  bacterial 
lipopolysaccharide (LPS) leading to Th1 differentiation 
and suppression of  Th2-dependent IgE responses8. 
CD14 protein is found either as membrane molecule 
(mCD14) expressed primarily on the surface of  mono-
cytes /macrophagesor as soluble form (sCD14) in serum9. 
Regulation of  CD14 gene expression and serum level 
of  sCD14 might affect the proportion of  Th1 to Th2 
cells, thereby influencing IgE responses and associated 
inflammatory phenotype in asthma. Thus, alterations of  
CD14 expression appear to be important in asthma, and 
is likely to be regulated, at least partially, at the gene level. 
A genetic variant in the promoter region of  the CD14, 
C(-159)T or rs2569190  has been found to be associated 
with altered levels of  sCD14 and total serum IgE9. Role 
of  CD14 polymorphism in asthma is widely explored in 
different ethnic population with diverse success i.e. Bald-
ini et al (1999)9 reported association of  CC homozygote 
with higher serum IgE level compared to CT and TT 
genotypes in atopic non-Hispanic white children. Similar 
findings were also reported by Buckova et al (2003)4 in 
Czech, Koppelman et al (2001)10 in Dutch and Leung et 
al (2003)11 in Hong Kong Chinese subjects. 
On the contrary, Kedda et al (2005)12 found no associa-
tion of  the polymorphism with asthma in Australian sub-
jects and Martinez et al (2007)13 proposed association of  
both C and T alleles of  the polymorphism with allergic 
manifestation depending upon level of  allergen exposure.
There is paucity of  data regarding aero-allergen sensiti-
zation among atopic patients in the Kolkata metropolitan 
area, particularly in asthma and CD14 polymorphisms in 
the same population. This study was undertaken to iden-
tify the common aero-allergen sensitizers among atopic 
patients and explore association of  CD14 polymorphisms 




i. Selection of  patients’ and control subjects: The 
study group composed of  950 patients clinically diag-
nosed as suffering from bronchial asthma at the Out-
patient Department of  the Allergy & Asthma Research 
Centre, Kolkata from 2010-2013. 
Inclusion criteria: Individuals diagnosed as asthmatic 
patients on the basis of  the criteria mentioned earlier14 
were case subjects. Briefly individuals having at least 6 
positive among the 8 symptoms (presence of  wheezy dys-
ponea;  presence of  frequent cough; presence of  ronchi; 
showing intervals of  relative/ complete freedom from 
symptoms; reports of  onset of  asthmatic bouts at an ear-
ly age;  with personal history of  atopic diseases such as 
infantile eczema, hay fever and or urticaria;  having family 
history of  atopy; report of  definite history of  allergy to 
inhalant allergen, particularly to house dust) were consid-
ered as suffering from bronchial asthma that later  con-
firmed by Spirometry. Individuals accompanying the case 
subjects, but not blood relative to the later, were selected 
as control. In total 220 healthy unrelated individuals (120 
male and 100 female) belonging to the same age group 
and locality (Kolkata) of  case and without any history of  
atopy were selected as control subject. The detailed in-
formation of  case and control individuals is described in 
table-1a and b.
Exclusion criteria: Cases with other organic and sys-
tematic diseases such as hypertension, diabetes, and also 
pregnant and lactating females were excluded. The per-
sonal and/or family history of  each individual patient was 
recorded in a well prepared questionnaire and a complete 
record of  the patients’ physical and clinical condition was 
also maintained. Stool examination was done for three 
consecutive days against each case subjects to exclude 
possible interference of  parasitic infections in the total 
IgE level of  sera.
ii. Patient population: 950 asthmatic patients were en-
rolled into the study group of  which 550 were male and 
400 female. Each category was again stratified according 
to age groups i.e. child (≤12Years), adolescent (12-19 
years) and adult (≥20 years), according to age of  asth-
ma onset i.e. childhood onset (< 20 years) and adult on-
set (≥20 years) and also according to disease severity i.e. 
mild, moderate and severe (Table-1a and b). 
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All (950) have been diagnosed to suffer from allergic 
asthma of  which 61.8% of  patients had also concomitant 
allergic rhinitis or urticaria or both.
Allergy skin tests
Skin prick test of  950 patients against 6 types of  pollen 
and 5 types of  molds (obtained from Credisol India Ltd. 
Mumbai) were done as described earlier14. The allergens 
were selected on the basis of  their predominance in en-
vironment of  Kolkata metropolis. The interpretation of  
skin prick test result was done following the method of  
Grater et al (1982)15. Only 2+ and above reactions (2+ to 
3+) were considered clinically significant.
Quantification of  total IgE level
Estimation of  total serum IgE was carried out in 950 pa-
tients by Enzyme Immuno Assay (EIA) using chemicals 
Pathozyme Immunoglobulin (Ref: OD 417) supplied by 
Glaxo Smithkline Pharmaceuticals Ltd., Mumbai. The 
concentration of  IgE is directly proportional to the color 
intensity of  the test and the assay was calibrated against 
the WHO16 standard for IgE.
Genotyping of  rs2569190
This was done in 220 asthmatic individuals (case) all of  
which were skin test positive and in an equal number of  
healthy unrelated control.
a. Genomic DNA isolation: Genomic DNA was isolat-
ed from peripheral blood leukocytes by the proteinase-K 
Table-1a: Detailed information of the case and control subjects 




Table-1b: Criteria for diagnosis of asthma severity 
 
  
Persistent Asthma  
Mild Moderate Severe  Asthma Symptoms ≥3days/week Daily Throughout the day  
Night time awakenings 




night/week 7 nights/week   
Frequency of Short-






limitation Extreme limitation   % predicted FEV1 
(mean±SEM) 80.3±1.5 72.5±1.9 58.1±2.8  
 
Characteristics Case Control 
Sex Male 550 (58%) 125 (57%) 
Female 400 (42%) 95 (43%) 
        
Age 
12 (Child) 158 (17%) 0 (0%) 
13-19 (adolescent) 60 (6%) 31 (14%) 
20 (Adult) 732 (77%) 189 (86%) 
  
Bronchial asthma (Doctors diagnosis) 950 (100%) 0 (0%) 
        
Age of Onset Child hood onset (<20 years) 432 (45%) 0 (0%) 
Adult Onset (≥20 years) 518 (55%) 0 (0%) 
  
Disease severity 
Mild (Persistent) 219 (23%) 0 (0%) 
Moderate (Persistent) 295 (31%) 0 (0%) 




Allergic rhinitis or Urticaria 493 (52%) 0 (0%) 
Both 94 (9.8%) 0 (0%) 
None 363 (38.2%) 220 (100%) 
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digestion of  cells followed by phenol/chloroform ex-
traction according to a standard method17.
b. PCR-RFLP: Polymerase chain reaction (PCR) was 
carried out in a volume of  20 μl reaction mixture con-
taining 50 ng genomic DNA, 4 pmol of  each primers 
(Forward, 5’-GTGCCAACAGATGAGGTTCAC-3’ and 
reverse 5’-CCTCTGTGAACCCTGATCAC-3’), 0.2 mM 
of  each deoxynucleotide triphosphates (Sibenzyme, Rus-
sia) and 1 unit of  Taq polymerase (Sibenzyme, Russia).
Following PCR, the product was digested with 2 units 
of  AVAII endonuclease (New England Biolabs) for over-
night, electrophoresed on 2% agarose gel and visualized 
by ethidium bromide staining on a gel documentation sys-
tem (Bio-Rad GS-800). Ava II is specific for the sequence 
GGTCC which is present in PCR products containing 
only CD14 (-159) T alleles. The PCR product is 497 base 
pairs in length, digestion of  which yielded bands of  497 
base pairs in CC homozygotes, 144 and 353 base pairsin 
TT homozygotes, and all the three bands (144, 353 and 
497 base pairs) in heterozygotes. 
c. DNA sequencing: Representative samples for each 
genotype from case and control were subjected to au-
to-sequencing for validation. Both strands of  each rep-
resentative genotypes were subjected to sequencing using 
ABI PRISMTM BD Terminator Cycle Sequencing kit (PE 
Applied Biosystems, Foster City, CA, USA) and electro-
phoresed in 3100-Avant Genetic Analyzer (PE Applied 
Biosystems Inc,USA). The obtained electropherograms 
were analyzed using the sequencing analysis software 
(version 1.01, Applied Biosystem). Identification of  spe-
cific sequence variations in the CD14 promoter region 
(-159 C/T) was done by aligning the forward and reverse 
complement sequences with the corresponding reference 
sequences (ensemble.org) using the Clustal W multiple 
alignment software program (European Bio Informatics 
Institute).
Data analysis
Chi-square test, student t-test and Analysis of  variance 
(ANOVA) were used to compare the allergic responses 
towards different aero-allergens, total serum IgE lev-
el and differences in genotype or allele frequencies of  
CD14 polymorphism in different age groups, genders 
etc. ANOVA was used to compare serum concentration 
of  total IgE among CD14 genotypes in different groups 
with specific allergic phenotypes. Odds ratio (OR) and 
confidence intervals were calculated. P-values less than 
0.05 were considered to be significant. All the statistical 
analysis was performed using statistical program Graph-
Pad PRISM (version-5, 2007). For case control study of  
CD14 polymorphism, the power was estimated using Ge-
netic power calculator17. Power was computed for an OR 
(Odds ratio) of  approximately 0.8 for the SNP and it was 
34%.  Allele frequencies were estimated as the following 
formula: (frequency of  homozygotes) + 1/2 (frequency 
of  heterozygotes).
Ethical approval
The Human Ethics Committee of  Allergy and Asthma 
Research center, Kolkata approved this study with refer-
ence number CREC-AARC Ref: 03/200012. Informed 





Of    950 patients, 638 (67%) gave positive immediate 
prick test reactions to at least one of  the 11 aero-allergen 
sensitizers; in the remaining 312 (33%), there was no im-
mediate skin reactivity (Table-2). 
The most common aero-allergen sensitizers were pollen, 
of  which most predominant one was Cocos nucifera (47%) 
followed by Caesalpinia sp (45%), Caricapapaya (40%), Aza-
dirachta indica (38%), Cynodon dactylon (36%) and Peltophori-
um sp (32%). Amongst mold category, most predominant 
one was Aspergillus fumigatus (18%) followed by Alternaria 
alternata (17%), Aspergillus niger (16%), Penicilium sp (14%) 
and Aspergillus tamarii (12%). While considering the ae-
ro-allergen sensitizers with respect to severity of  reac-
tions, Cocos nucifera was found to be most potent i.e. 7% 
(66/950) of  patients showed 3+ or more sensitivity to 
it, followed by Caesalpinia (5%, 47/950) and Peltophorium 
(3%, 29/950) (Data not shown). No significant difference 
in the distribution of  overall skin test positive individuals 
was found between male and female (p=0.285). Howev-
er, when allergen sensitizers were considered individually, 
frequency of  sensitive individuals was found to be signifi-
cantly more among males than females for Cocos nucifera, 
(p=0.04) and Cynodon dactylon (p=0.023) among pollen and 
Aspergillus fumigatus (p=0.035), Aspergillus niger (p=0.034), 
and Penicilium (p=0.033) among molds (Table-2). 
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The frequency of  skin test positive individuals was high-
est among children, which decreased gradually and sig-
nificantly in adolescents and adults (Figure-1a). Further-
more, childhood onset group had significantly higher 
frequency of  skin test positive individuals than that of  
adult onset (Figure-1b).  
 
 Figure 1: Relative proportion of skin test positive to skin test negative patients in child 
(≤12years), adolescent (13-19 years) and adult (≥20 years)  (A) and according to age at 
onset of bronchial asthma i.e. childhood onset (<20 years) and adult onset (≥20 Years) (B). 
* P<0.05 (Chi-square test).      
Table-2: Result of skin prick test for pollen and molds. 
 
Skin prick test (positive) 
  Male Female p value 
Total               638/950 (67%) 377/550 (68%) 261/400 (65%) 0.285 
Pollen 
Cocos nucifera (300/638, 47%) 190/377 (50%) 110/261 (42%) 0.04* 
Caesalpinia sp (285/638, 45%) 164/377 (44%) 121/261 (46%) 0.47 
Carica papaya (253/638, 40%) 148/377 (39%) 105/261 (40%) 0.8 
Azadirachta indica (241/638, 38%) 142/377 (38%) 99/261 (38%) 0.945 
Cynodon dactylon (231/638, 36%) 150/377 (38%) 81/261 (31%) 0.023* 
Peltophorium sp (207/638, 32%) 122/377 (32%) 85/261 (32%) 0.956 
Mold 
Aspergillus fumigatus (115/638, 18%) 78/377 (21%) 37/261 (14%) 0.035* 
Alternaria alternata (110/638, 17%) 67/377 (18%) 43/261 (16%) 0.669 
Aspergillus niger (99/638, 16%) 68/377 (18%) 31/261 (12%) 0.034* 
Penicilium sp (91/638, 14%) 63/377 (17%) 28/261 (11%) 0.033* 
Aspergillus tamari (76/638, 12%) 47/377 (12%) 29/261 (11%) 0.603 
* P < 0.05 
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Total IgE level
The average IgE level of  total 950 patients was 528 IU/
mL (95% confidence interval 505-551 IU/mL). No signif-
icant difference in the mean IgE level was found among 
male and female concordant with the result of  skin prick 
test. For both sexes, a significant negative correlation of  
total IgE level was found with the age of  patients i.e.  Chil-
dren have the highest level of  total IgE followed by ado-
lescents and adults (Figure-2a). We also observed signifi-
cantly higher IgE levels in patients with childhood-onset 
of  asthma compared to those of  adult-onset (Figure-2b) 
and across the patients with increase of  severity of  the 
disease (Figure2c) . 
 
  
 Figure-2: Geometric mean of total IgE level in child (≤12years), adolescent (13-19 years) 
and adult (≥20 years) (a) according to age at onset of bronchial asthma i.e. childhood onset 
(<20 years) and adult onset (≥20 Years) (b) and according to disease severity (c). * 
P<0.05 (analysis of variance and t-test).  
Genotype frequency of  the CD14 promoter region
Two alleles (C and T) and three respective genotypes (CC, 
CT and TT) were readily detected for the CD14 promot-
er region at location -159 relative to transcription start 
site (Figure-3A&B). Genotype frequencies in cases and 
controls did not show any significant departure from the 
Hardy-Weinberg equilibrium (p = 0.89 and 0.92, respec-
tively).  The frequency of  heterozygous (CT) genotype 
was highest than either of  homozygotes (CC and TT)in 
both case and control populations (Table-3a). There is no 
significant difference in the genotype or allelic frequen-
cies for the CD14 polymorphism between asthmatic pa-
tients and controls (p= 0.178 and 0.177 respectively). The 
patients included in this analysis were all skin test posi-
tive and among them, there was a significant difference 
of  allele and genotype distribution for CD14 polymor-
phism between childhood onset (<20 years) and adult on-
set groups (≥ 20 years) (p=0.004 and 0.001 respectively) 
(Table-3b) and across individuals with increase of  disease 
severity (p=0.002 and 0.009 respectively) (Table-3c). The 
homozygous CC genotype and also C allele at CD14 -159 
were predominant in patients with childhood onset of  
asthma compared to those of  adult onset and in patients 
with moderate and severe form of  the disease than those 
with a mild form of  asthma. 
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Figure-3:  Genotyping of rs2569190 and its association with total serum IgE level.  
A. Detection of rs2569190 polymorphism by restriction fragment length polymorphism 
(RFLP) analysis. CC homozygote is in lane 5; TT homozygote is in lane 1 and CT 
heterozygotes are in lanes 2, 3, and 4.  
B. Representative chromatogram showing rs2569190 polymorphism and arrows indicate the 
polymorphic locus; CC homozygote (a), CT heterozygote (b) and TT homozygote (c).  
C. Scatter diagram showing total IgE levels in IU/ml and association with three rs2569190 
genotypes; a. overall association, b. association with childhood onset (<20 years), c. 
association with adult onset (≥20 Years).  * P<0.05. 
Association of  CD14 promoter region genotypes 
with IgE levels
Total serum IgE level of  case subjects were also tested 
for associations with SNP genotypes of  the CD14 pro-
moter region (Figure-3C). There was a significant increase 
(P=0.007) in total serum IgE levels in carriers of  CC gen-
otype compared to the CT and TT. However, when the 
patients were sub-divided according to age of  disease on-
set,   the differences in serum IgE levels remained signif-
icant (P=0.002) in the early onset group only, but in the 
late onset group of  our study population, this association 
did not reach to statistical significance (p=0.868).
Discussion
With a background of  increased incidence of  bronchial 
asthma in Kolkata population, this study aimed to ana-
lyze environmental and genetic factors influencing such 
multifactorial disease condition. Among total 11 com-
mon out-door aero-allergens sensitizers (6 pollen and 5 
molds), the most predominant one found in this analysis 
was Cocos nucifera followed by Caesalpenia sp, Caricapa paya 
etc, all of  which belong to pollen category. This finding 
is in agreement with our previous study2 indicating that 
pollen category is a more predominant aero-allergen 
over mold category in out-door air of  Kolkata. On the 
contrary, mold category was found to be more common 
over pollen among asthmatic patients of  South-Western 
Iran18 indicating importance of  geographic location and 
associated conditions in this respect. A cross reactivity 
of  Cocos nucifera with Areca catechue, Phoenix sylvestris and 
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some other members of  Palmacae family was reported19 
from Eastern India. Surprisingly, very low skin sensitivity 
of  both Areca and Phoenix as compared to Cocos nucifera 
did not support such cross reactivity in our study pop-
ulation. In the present study, significantly higher num-
bers of  skin test positive patients along with concordant 
higher level of  total serum IgE were found among child 
and adolescents than in adults and this was preliminarily, 
in accordance, to the idea20 of  decline of  asthma inci-
dence and severity with age (Cut off  values for normal 
IgE leveling blood: 4-10 years, <250IU/ml; 10-16 years, 
<200IU/ml;adults, <100IU/ml21). However, significant 
difference of  skin test sensitivity and total IgE between 
childhood onset and adult onset groups imposed more 
importance on age of  disease onset and some differential 
genetic interplay might be involved forsuch phenotypic 
heterogeneity. Similarly, Segala et al (2000)22 found phe-
notypic heterogeneity between childhood onset and adult 
onset asthma and reported comparatively more severity 
in adults having their disease onset in childhood. 
Furthermore Craig et al (2010)23 also reported higher 
frequency of  negative skin test and lower level of  total 
serum IgE in patients with late onset asthma. Among 
the reported genetic polymorphisms involved in allergic 
manifestations through modulating TH2 mediated IgE 
response, CD14 C-159T was most widely studied. We 
found no significant difference in the allele and genotype 
frequencies of  CD14 promoter polymorphism between 
asthmatic subject and healthy control; therefore, the gene 
did not seem to constitute a risk factor for the disease 
development. Similar findings have also been reported 
by Tan et al (2006)24 and Buckova et al (2001)4 in dif-
ferent IgE mediated allergic manifestations. Association 
of  CD14 with asthma severity was widely explored in 
different population with conflicting results: Baldini et al 
(1999)9 reported that C allele of  the CD14 polymorphism 
was associated with atopy in non-hispanic white children 
as CC genotype was significantly more frequent among 
skin test positive individuals and associated with higher 
serum IgE than CT and TT. Similar finding was reported 
by Buckova et al (2003)4 in Czech children sensitized to 
mold allergen. On the contrary Perin et al (2011)25 report-
ed association of  C allele of  CD14 C(-159)T with severity 
of  non-atopic asthma in Slovenian children and Kedda 
et al (2005)12 found no association of  the polymorphism 
with asthma or asthma severity in an Australian adult 
population.
In present study  with 220  skin test positive asthma pa-
tients, C allele was  significantly more frequent in child-
hood onset group only and CC genotype was significantly 
correlated with higher level of  total serum IgE, whereas 
no such significant association was found in adult on-
set group. Therefore, childhood onset and adult onset 
of  asthma might be considered as specific sub-sets of  
the disease in which differential genetic predisposition 
might be interplaying and accounting for their pheno-
typic heterogeneity. This might also be an explanation 
to the inconsistent results reported by different authors 
on association of  CD14 in atopic phenotype in addition 
to ethnicity. However, further study is warranted in this 
respect to establish the genetic heterogeneity existing be-
tween childhood onset and adult onset of  asthma.
Conclusion
Aero-allergens of  pollen category seemed to be more 
prevalent and cause more severe sensitization in Kolkata 
metropolis than that of  mold.This might have implica-
tions in designing preventive strategies. Childhood onset 
asthma seemed to be more severe than that of  adult onset 
and this might have some genetic background. Therefore 
effective treatment plan should be designed separately for 
these two disease sub-sets in accordance.
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